Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease

被引：0
作者：
Huan Liu
Yongnan Lyu
Di Li
Yan Cui
Yun Huang
Wen Dai
Yan Li
机构：
[1] Wuhan Univ,Dept of Clinical Laboratory
[2] Renmin Hospital,Dept of Cardiology
[3] Wuhan Univ,undefined
[4] Renmin Hospital,undefined
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Growth differentiation factor-15; Testosterone; Coronary artery disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome Observations From PROVE IT-TIMI 22
    Bonaca, Marc P.
    Morrow, David A.
    Braunwald, Eugene
    Cannon, Christopher P.
    Jiang, Songtao
    Breher, Stephanie
    Sabatine, Marc S.
    Kempf, Tibor
    Wallentin, Lars
    Wollert, Kai C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (01) : 203 - 210
  • [32] Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease
    T. Soeki
    Yoshiyuki Tamura
    Hisanori Shinohara
    Hideji Tanaka
    Kanji Bando
    Nobuo Fukuda
    Heart and Vessels, 2000, 15 : 105 - 111
  • [33] Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease
    Soeki, T
    Tamura, Y
    Shinohara, H
    Tanaka, H
    Bando, K
    Fukuda, N
    HEART AND VESSELS, 2000, 15 (03) : 105 - 111
  • [34] Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients
    Fu, Lu
    Gao, Qian-Ping
    Shen, Jing-Xia
    ASIAN JOURNAL OF ANDROLOGY, 2008, 10 (02) : 214 - 218
  • [35] Raised circulating soluble growth differentiation factor 15 is negatively associated with testosterone level in hypogonadic men with type 2 diabetes
    Mei, Yufeng
    Lyu, Yongnan
    Le, Juan
    Li, Di
    Liu, Hang
    Zhao, Zhiming
    Li, Yan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (07)
  • [36] Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: Implication for coronary arteriosclerosis
    Watanabe, K
    Fukuda, H
    Sueda, S
    Funada, J
    Kitakaze, M
    Sekiya, M
    CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (02) : 147 - 153
  • [37] Metabolism of Hepatocyte Growth Factor in the Heart in Patients with Coronary Artery Disease: Implication for Coronary Arteriosclerosis
    Kouki Watanabe
    Hiroshi Fukuda
    Shozo Sueda
    Jun-ichi Funada
    Masafumi Kitakaze
    Michihito Sekiya
    Cardiovascular Drugs and Therapy, 2001, 15 : 147 - 153
  • [38] Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis
    Huang, Feng
    DIABETES THERAPY, 2018, 9 (03) : 1061 - 1072
  • [39] Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes
    Kim, Won Jin
    Kim, Sang Soo
    Lee, Han Cheol
    Song, Sang Heon
    Bae, Min Jung
    Yi, Yang Seon
    Jeon, Yun Kyung
    Kim, Bo Hyun
    Kim, Yong Ki
    Kim, In Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (05) : 586 - 590
  • [40] Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis
    Feng Huang
    Diabetes Therapy, 2018, 9 : 1061 - 1072
12345